ScholarIQanswers from OpenAlex
Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING)
PaperCitations, authors & open-access status
Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING) is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING) have?
ScholarIQcitation count
Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING) has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING) published?
ScholarIQyear
Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING) has 2024 year in the ScholarIQ index.
What is the open-access status of Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING)?
ScholarIQoa status
Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING) has green oa status in the ScholarIQ index.
What is the DOI of Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING)?
ScholarIQdoi
The DOI for Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING) is on the source record.
What is the OpenAlex record for Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING)?
ScholarIQopenalex
The OpenAlex for Study Protocol: The Use of Rituximab in Nephrotic Glomerulonephritis (TURING) is on the source record.